(PRESS RELEASE) BUCHAREST, Romania, 19-Mar-2020 — /EuropaWire/ — The Company informs its shareholders and investors that the Hungarian Competition Authority (Gazdasagi Versenyhivatal, hereinafter “GVH”) has issued on 18 March 2020 a new decision approving the acquisition by our Hungarian subsidiary, … Read the full press release
Posted in Business, Financial, Healthcare, Hungary, Investment, Law, Media, News, Romania, Technology, Telecom
Tagged acquisition, AFM, Android TV-based entertainment service, ASF, Bucharest Stock Exchange, Business Continuity, buy back shares, buy-back program, BVB, Class A shares, Class B shares, Competition, conference call, coronavirus, COVID-19, Digi, Digi Communications, Digi Communications 2018 Preliminary financial results, Digi Communications Conference Call, Digi Communications NV, Digi HU, DIGI symbol, DIGI symbol 20 - 24 Jan 2020 transactions, DIGI Távközlési és Szolgáltató Kft., directors stock option plans, Dutch Authority for the Financial Markets, employees stock option plans, equity reserves, financial transactions, Gazdasági Versenyhivatal, Hungary, Investor Relations, investors, Invitel, Invitel acquisition, Invitel Távközlési Zrt, IPO, market, mobile services, MVNO, Regulation, Romania, Romanian Financial Supervisory Authority, Romanian National Securities Commission, romanian telecommunications provider, Securities, Serghei Bulgac, shareholders, shares, shares buy-back, shares conversion, Spain, stock option plans, Telecom Market, TELECOMMUNICATION PROVIDER, telecommunications, telecommunications services, The Hungarian Competition Council, transactions, tv
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
